IBD
Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease
July 2024 - VOLUME 20, ISSUE 7
Case Study in IBS-C
A Case Study in the IBS-C Management Continuum: Assessing Patient Response and Tailoring Treatment
Patient Case A 60-year-old woman presented to the clinic with a chief complaint of constipation (Table 1). She reported that she had been experiencing altered bowel […]
In This Issue
From Recent Issues
Feature
Clinical Guide to Navigating the Landscape of Biosimilars for Inflammatory Bowel Disease
Abstract: Annual out-of-pocket expenditures for patients with inflammatory bowel disease (IBD) are estimated to be as high as $41,000, with medications, such as biologics, being one […]
Feature
Family Planning for Patients With Inflammatory Bowel Disease in the Post-Dobbs Era
Abstract: Federal protections for abortion care in the United States ended in June 2022. For people with inflammatory bowel disease (IBD) who are capable of pregnancy, […]
Feature
A Clinical Review of Noninvasive Tests for Hepatic Fibrosis
Abstract: Identifying hepatic fibrosis is paramount in managing patients with chronic liver disease. The etiology of liver disease can be owing to many factors, including chronic […]
Supplements
Highlights in Crohn’s Disease From Digestive Disease Week 2024
A Review of Selected Presentations From DDW 2024 May 18-21, 2024 • Washington, DC Upadacitinib Treatment Is Associated With Improved Clinical and Quality of Life Outcomes […]
Highlights in Ulcerative Colitis From Digestive Disease Week 2024
A Review of Selected Presentations From DDW 2024 May 18-21, 2024 • Washington, DC Extended Induction Response Over Time in Patients With Moderately to Severely Active […]
Highlights in IBS-C From Digestive Disease Week 2024
A Review of Selected Posters and CME Symposium From DDW 2024 May 18-21, 2024 • Washington, DC Efficacy of Tenapanor in Patients With IBS-C: A Post […]